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Based on user feedback, NHSN has modified the NHSN Newsletter format to make it easier for 
users to navigate to the appropriate articles for their facility type and NHSN Component 
participation. The Newsletter has been split into NHSN Component-specific sections: Patient 
Safety, Long Term Care Facility, Healthcare Personnel Safety, Dialysis, Biovigilance, and general 
NHSN information. Users can use the direct links in the Table of Contents below to navigate to 
the exact section of the Newsletter they wish to read. 
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The following data must be entered into NHSN by November 15, 2014 for facilities that participate in certain CMS 
quality reporting programs.  
 
Acute Care Hospitals that participate in the Hospital Inpatient Quality Reporting (IQR) Program:  
2014 Quarter 2 (April 1 – June 30) CLABSI and CAUTI data (ICU locations only)  
2014 Quarter 2 (April 1 – June 30) COLO and HYST SSI data  
2014 Quarter 2 (April 1 – June 30) MRSA Bacteremia and C.difficile LabID Events (FacWideIN, all HO and CO)  
 
Cancer Hospitals that participate in the PPS-Exempt Cancer Hospital Quality Reporting Program:  
2014 Quarter 2 (April 1 – June 30) CLABSI and CAUTI data (all bedded inpatient care locations)  
2014 Quarter 2 (April 1 – June 30) COLO and HYST SSI data  
 
Inpatient Rehabilitation Facilities (IRFs) that participate in the IRF Quality Reporting Program:  
2014 Quarter 2 (April 1 – June 30) CAUTI data (all bedded inpatient locations)  
 
Long-Term Acute Care Facilities (LTACs/LTCHs) that participate in the LTCH Quality Reporting Program:  
2014 Quarter 3 (July 1 – September 30) CLABSI and CAUTI data (all bedded inpatient locations)   
 
Please make sure at least one individual at your facility can access NHSN via an active digital certificate or SAMS and 
has been assigned appropriate user rights in NHSN so they may enter and view the facility’s data. To ensure your data 
have been correctly entered into NHSN, please make sure to verify that: 1) your monthly reporting plans are complete, 
2) you've entered appropriate summary and event data or checked the appropriate no events boxes, and 3) you've 
cleared all alerts from your NHSN facility homepage. For additional guidance on ensuring your data are accurately sent 
to CMS for Quality Reporting purposes, please visit our website and navigate to the appropriate section(s) for your 
facility type: http://www.cdc.gov/nhsn/cms/index.html.  
  
If you have any questions, please contact the NHSN Helpdesk: NHSN@cdc.gov. 
Patient Safety Component 
Reminder! Data for CMS Quality Reporting Programs due Soon! 
New NHSN Reporting to fulfill CMS Quality Reporting Programs  
CMS has recently finalized requirements for their quality reporting programs. Below is a list of the recently finalized 
requirements along with previously finalized requirements for reporting in NHSN that will be going into effect on either 
October 1, 2014 (for the 2014-2015 influenza season) or January 1, 2015. 
 
Acute Care Hospitals that participate in the CMS Hospital Inpatient Quality Reporting (IQR) Program: 
Beginning with this 2014-2015 influenza season, acute care hospitals should begin reporting healthcare worker 
influenza vaccination summary data from personnel working in hospital outpatient departments along with the counts 
from personnel working in the inpatient locations of the acute care hospital. The reporting period for this new 
requirement is October 1, 2014 – March 31, 2015. For more information on training materials please see the article 
“Reminders for 2014-2015 Influenza Vaccination Summary Data Reporting” on page 18 of the newsletter. 
 
Beginning January 1, 2015, acute care hospitals should begin reporting CLABSI and CAUTI data from all patient care 
locations that are mapped as NHSN adult and pediatric medical, surgical, and medical/surgical wards, in addition to the 
ongoing reporting from ICUs. For more information on how to map these units appropriately within your NHSN facility, 
please see the article “Mapping locations for CMS IPPS 2015 CLABSI and CAUTI Reporting” on page 12 of the 
newsletter. 
(New NHSN Reporting continued on Page 3) 
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New NHSN Reporting to fulfill CMS Quality Reporting Programs (continued) 
Cancer Hospitals that participate in the CMS PPS-Exempt Cancer Hospital Quality Reporting Program:  
There are no additions to the reporting requirements for PPS-Exempt Cancer Hospitals for 2015. 
 
Inpatient Rehabilitation Facilities (IRFs) that participate in the CMS IRF Quality Reporting Program: 
Beginning with this 2014-2015 influenza season, IRFs should begin reporting healthcare worker influenza vaccination 
summary data. The reporting period for this new requirement is October 1, 2014 – March 31, 2015. For more 
information on training materials please see the article “Reminders for 2014-2015 Influenza Vaccination Summary Data 
Reporting” on page 19 of the newsletter. 
 
Beginning January 1, 2015, IRFs should begin reporting MRSA Bacteremia and C.difficile LabID Events by location from 
all CMS IRF units within acute care hospitals or at the facility wide inpatient level (FacWideIN) if free-standing. For 
more information on this new requirement and how to correctly report these events, please see the article “New 
Reporting for Inpatient Rehabilitation Facilities (IRFs): MRSA & CDI LabID Events” on page 13 of the newsletter. 
 
Long-Term Acute Care Facilities (LTACs/LTCHs) that participate in the CMS LTCH Quality Reporting Program:  
Beginning with this 2014-2015 influenza season, LTACs should begin reporting healthcare worker influenza vaccination 
summary data. The reporting period for this new requirement is October 1, 2014 – March 31, 2015. For more 
information on training materials please see the article “Reminders for 2014-2015 Influenza Vaccination Summary Data 
Reporting” on page 19 of the newsletter. 
 
Beginning January 1, 2015, LTACs should begin reporting MRSA Bacteremia and C.difficile LabID Events at the facility 
wide inpatient level (FacWideIN). For more information on this new requirement and how to correctly report these 
events, please see the article “New Reporting for Long Term Acute Care facilities (LTACs): MRSA & CDI LabID Events” on 
page 13 of the newsletter. 
 
Ambulatory Surgery Centers (ASCs) that participate in the CMS ASC Quality Reporting Program: 
Beginning with this 2014-2015 influenza season, ASCs should begin reporting healthcare worker influenza vaccination 
summary data. The reporting period for this new requirement is October 1, 2014 – March 31, 2015. For more 
information on training materials please see the article “Reminders for 2014-2015 Influenza Vaccination Summary Data 
Reporting” on page 19 of the newsletter. 
 
 
The complete list of CMS reporting requirements and due dates can be found here: 
 Reporting Requirements and Deadlines in NHSN per CMS Current Rules: http://www.cdc.gov/nhsn/PDFs/CMS/CMS
-Reporting-Requirements-Deadlines.pdf.   
 Healthcare Facility HAI Reporting Requirements to CMS via NHSN - Current and Proposed Requirements: http://
www.cdc.gov/nhsn/PDFs/CMS/CMS-Reporting-Requirements.pdf.  
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 NHSN HAI Surveillance Changes for 2015  
Use of NHSN has expanded remarkably over recent years due to CMS quality improvement programs and state 
mandates that require a variety of healthcare facility types to report multiple healthcare-associated infections (HAIs) 
and other process of care measures into the system. These new uses and users of the system have prompted new 
scrutiny of the NHSN definitions and criteria for HAIs and other reportable events, and further examination of the 
business rules CDC uses to build and maintain the NHSN application. CDC’s own, in-depth assessment of NHSN, coupled 
with invaluable feedback from system users and subject matter experts, have led to important changes in definitions, 
criteria, and business rules, all of which are intended to enhance the system’s performance and produce new benefits 
for patient and healthcare worker safety. These revisions are intended to better organize, update, simplify, and align 
criteria and definitions, and at the same time decrease subjectivity and improve ease of data collection and entry. We 
strive to maintain epidemiologic standardization and clinical relevance, while increasing potential for more purely 
electronic data capture. The goal is to deliver a reliable source of high quality data for analysis and action at the facility, 
local, state, and national levels.  
The revisions and enhancements that are described on the following pages will be implemented in the NHSN applica-
tion in late-January 2015. By introducing the definition and criteria changes for several HAIs simultaneously in January 
2015, and retaining definitions and criteria previously established for other HAIs, CDC will be able to use this single 
calendar year as the new baseline year for its HAI SIR calculations. The 2015 data reported to NHSN will provide the 
baseline for calculating the SIRs for 2016 and subsequent years. SIRs calculated for the 2015 data will use the current 
older baselines. CDC has no near-term plans for revising the HAI definitions and criteria any further beyond these 
changes. The primary impetus for future changes to HAI definitions and criteria is likely to come from the increasing 
use of electronic health record systems and the opportunity to take greater advantage of healthcare data in electronic 
form for surveillance purposes. When changes are made again to NHSN, users will see a very strong move to fully 
electronic capture of required data and determination of reported events. The timeline for these next changes is 
currently 3-5 years. We thank our users for their continuous support and efforts to maintain data accuracy, integrity, 
and reliability, through careful attention to the definitions and criteria put forth in the NHSN protocols and guidance.  
The following changes will be included in the NHSN Protocols for 2015. NHSN users are to implement these new 
protocols and reporting guidelines for all numerators and denominators with dates of January 1, 2015 and forward. 
General NHSN HAI Changes 
1. NHSN will move away from framing elements of an infection criterion using a “gap day” methodology. Instead all 
elements of a specific infection criterion will be required to occur within a set time period which will be known as 
the NHSN Infection Window Period defined below.  
 
 NHSN Infection Window Period (Does NOT apply to SSI, VAE, or LabID Event surveillance):  
The NHSN Infection Window is defined as the 7-day period during which all site-specific infection criterion 
must be met. It includes the day the first positive diagnostic test, that is an element of the site-specific 
criterion, was obtained (i.e., laboratory specimen collection date, imaging test date, procedure or exam date, 
physician diagnosis, initiation of treatment), the 3 calendar days before and the 3 calendar days after. For site 
specific infection criterion that do not include a diagnostic test, the first documented localized sign and/or 
symptom that is an element of the NHSN infection criterion should be used to define the window period (e.g., 
diarrhea, site specific pain, etc.).  
 
The diagnostic test included as part of each site-specific infection criterion will be used as the starting point for 
defining an NHSN infection and the surrounding NHSN Infection Window Period. Gap Days will no longer be 
used to determine fulfillment of infection criteria. 
 
(General NHSN HAI Changes continued on Page 5)  
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 NHSN HAI Surveillance Changes for 2015 (continued)  
General NHSN HAI Changes (continued) 
2. The NHSN Date of Event will change in 2015 from the date of the last element of the infection criterion to the date 
of the first element of the infection criterion. 
 
 Date of Event (Event Date) -  (Does NOT apply to VAE or LabID Event surveillance) - The date of event is the 
date that the first element used to meet a CDC/NHSN site-specific infection criterion occurs for the first time 
within the defined seven-day infection window period. 
 
Note that the Date of Event will still be used to distinguish between infections that are Present on Admission 
(POA) and those that are Healthcare-associated Infections (HAI). Any infections with Date of Event during the 
POA timeframe (i.e., the day of admission, 2 days before, and the day after) are considered POA. Those with 
Date of Event on or after hospital day 3, with the day of admission to an inpatient location being day 1, are 
healthcare-associated infections for NHSN surveillance.   
 
3. In 2015, NHSN will institute a Repeat Infection Timeframe (RIT) (Does NOT apply to SSI, VAE, or LabID Event 
surveillance). The RIT is a 14-day period during which repeat infections of the same type will not be reported to 
NHSN. If additional site specific specimens are collected within the RIT and new pathogens are identified those 
pathogens should be added to the original infection.  
 
The RIT will mean that facilities will no longer have to determine if symptoms of a previous infection have resolved 
and/or treatment completed in order to identify a new infection. Instead, no new same-type infections will be 
allowed to be reported within 14 days of each other, with the Date of Event for the first infection, being day 1 of 
the RIT. 
 
4. NHSN will use a Secondary Bloodstream Infection (BSI) Attribution Period to determine the time period during 
which, a BSI, can be attributed as secondary to another infection site, if all other required guidelines (i.e. Secondary 
BSI Guideline) are met. This time period will include the Infection Window Period of the primary infection as well as 
that infection’s Repeat Infection Timeframe (RIT). The length of this attribution period will vary from 14-17 days, 
depending on where the date of event falls within the Infection Window Period. (The secondary BSI attribution 
period does not apply to SSI, VAE, or LabID Event surveillance. See the secondary BSI attribution time period 
information in the 2015 NHSN Patient Safety Component manual for more information about BSIs secondary to 
SSIs.) 
 
More guidance for all of these definitions will be provided in the NHSN Manual which will be distributed before the 
New Year, as well as by Hot Topic webinars that will be posted to the NHSN Training website by mid-December.   
 
5. The definitions for infections found in the chapter “CDC/NHSN Surveillance Definitions for Specific Types of 
Infections” (i.e. Chapter 17 of the NHSN manual) have been updated. The infection definitions in this chapter of the 
NHSN Patient Safety Component Manual had not been updated in a thorough and significant manner since the late 
1990s. As a result many of the definitions were out of date. Because these criteria are used not only to identify 
primary infections, but also as a tool of the Secondary BSI Guide to distinguish between primary and secondary BSI, 
they have been reviewed and updated by CDC staff to better reflect current diagnostic tests/procedures and 
likelihood of secondary BSI. Since the changes are many, we encourage surveillance staff to review them in their 
entirety and perhaps to print the finalized NHSN Protocols when they become available in early December so as to 
have available while performing HAI surveillance 
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 NHSN HAI Surveillance Changes for 2015 (continued)  
BSI Changes 
Definitional Change: Secondary Bloodstream Infections (BSI) Guide    
 Determination that an organism in a blood culture is a “logical pathogen” for another specific site of infection 
will no longer be used as part of the NHSN Secondary BSI.  
 In order to qualify as a secondary BSI, the positive blood culture must occur within the NHSN Infection Window 
for the primary infection or the Repeat Infection Timeframe (RIT). (See definitions for the NHSN Infection 
Window and RIT in the “General NHSN HAI Changes” section above.) 
 
Additional Protocol Change 
 Core temperatures will no longer be required to document infant fevers. The documented temperature should 
be used in all NHSN HAI surveillance. Do not convert any temperatures based on route, even if hospital policy 







Reducing NHSN Data Collection Burden: Introduction of Once-Weekly Sampling for CLABSI & CAUTI 
Denominator Data 
In January 2015, NHSN will introduce an alternative method for collecting NHSN CLABSI and CAUTI denominator data 
for use in eligible ICU and ward location types. This method reduces  staff time spent on manual collection of denomi-
nator data by requiring  data collection on the number of patient-days and central-line days or urinary-catheter days on 
just a single day once a week (for example, on every Tuesday) during a month, but also requires the total number of 
patient-days for the month. Upon entry of the collected monthly data into NHSN, an estimate of central-line days or 
urinary-catheter days will be automatically calculated and used for CLABSI and CAUTI denominator data. 
 
To ensure the accuracy of the estimated denominator data, only ICU and ward location types with 75 or more device-
days per month are eligible to use this alternative method. Review of your prior year of CLABSI or CAUTI denominator 
data in NHSN will help determine which locations are eligible. The traditional method (counting every day of a month) 
for CLABSI and CAUTI denominators remains available for all NHSN users. The alternative method of data collection 
was tested rigorously1-3 in a variety of NHSN locations. More detailed instructions on use of the alternative method will 
be included in the 2015 NHSN Protocol. 
 
1: Klevens M et al. Sampling for collection of central line day denominators in surveillance for healthcare -associated bloodstream infections. ICHE 2006;27:338-42. 
2: Thompson ND et al. Evaluating the Accuracy of Sampling to Estimate Central Line–Days: Simplification of NHSN Surveillance Methods. ICHE 2013;34(3):221-228. 
3: See I et al.  IDWeek 2012 (Abstract #1284): Evaluation of Sampling Denominator Data to Estimate Urinary Catheter - and Ventilator-Days for the NHSN. San Diego, 
California. October 19th, 2012. 
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 NHSN HAI Surveillance Changes for 2015 (continued)  
UTI Changes 
Definitional Changes  
The Urinary Tract Infections (UTI) definitions will no longer include: 
 Symptomatic UTI (SUTI) criteria 2 and 4 due to removal of the following elements: 
o Colony counts of less than 100,000 CFU/ml  
o Urinalysis results  
 Urine cultures that are positive only for yeast, mold, dimorphic fungi, or parasites 
 Uropathogen List for Asymptomatic Bacteremic UTI (ABUTI) 
 
Additional Protocol Changes 
1. Scenario: 
 Patient is > 65 years of age, AND 
 Patient has not had an indwelling urinary catheter on the day of ABUTI or the day before, AND 
 Patient meets all other ABUTI definitional requirements  
 
Previous to January 1, 2015 in the above scenario, the patient would not have met the ABUTI criteria because all 
UTI symptoms, including fever were excluded. For 2015, since fever alone is not a specific symptom of UTI in non-
catheterized, elderly patients (i.e., > 65 years of age) presence of fever alone will not exclude ABUTI in this 
population only.  
2. Users will also note that the seldom used symptom “dysuria” can no longer be used to meet the infant criteria for 
SUTI (SUTI 4). 
3. Core temperatures will no longer be required for infant fevers. Additionally, for all NHSN HAI surveillance, no 
conversion of temperatures based on route should be performed, even if hospital policy exists to say otherwise. 
Instead, facilities will use the documented temperature for all NHSN HAI surveillance. 
4. The SUTI 1a criterion will be changed, in part, to read “Patient has an indwelling urinary catheter in place for the 
entire day on the date of event and such catheter had been in place for > 2 calendar days, on that date (day of 
device placement = Day 1).”   
 
What These Changes Mean for Facilities Reporting UTIs to NHSN in 2015 
 Only urine cultures with a colony count of at least 100,000 CFU/ml for at least one bacteria will be used to 
meet NHSN UTI criteria. 
 Only bacteria will be accepted as causative organisms of UTI. 
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 NHSN HAI Surveillance Changes for 2015 (continued)  
VAE Changes 
1. The third tier of the VAE algorithm will be consolidated and represented as one specific event: PVAP.  
The PVAP specific event will replace possible VAP and probable VAP specific events in the third tier of the VAE 
surveillance algorithm. This modification provides simplification and addresses issues related to differences in how 
laboratories process specimens and report findings. This change is also consistent with the plan for analysis where 
possible VAP and probable VAP will be combined. 
 
After satisfying the requirements of the VAC and IVAC definitions there will be three pathways to satisfy the PVAP 
definition: 
i. Quantitative or semi-quantitative equivalent culture result meeting specified growth thresholds, without 
purulent respiratory secretions 
ii. Culture result that does not satisfy the specified quantitative or semi-quantitative equivalent growth 
thresholds, with purulent respiratory secretions  
iii. Other positive laboratory test (positive pleural fluid culture, lung histopathology, diagnostics for Legionella or 
specified respiratory viruses) 
 
2. Pathogens typically acquired from the environment and that are either not known to be acquired in healthcare 
settings or have rarely been reported to be healthcare-associated will no longer be available for meeting the 
PVAP definition. 
The following community associated fungal pathogens will be excluded:  
 Cryptococcus  






3. An exception regarding the selection of daily minimum PEEP and FiO2 settings will be provided:  
The daily minimum PEEP and FiO2 values are defined as the lowest values during a calendar day that are set on the 
ventilator and maintained for at least 1 hour. An exception to this rule will occur when there is no value 
documented to have been maintained for at least 1 hour during a calendar day. In that circumstance, the daily 
minimum value will be represented by the lowest value documented for that calendar day. This modification 
provides simplification and consistency for determining the daily minimum PEEP/FiO2 in select circumstances. 
 
Examples of when this exception may apply include the following: 
 Ventilator support  is initiated late in the calendar day 
 Ventilator support  is removed early in the calendar day 
 Ventilator settings are changed frequently throughout the calendar day such that no setting is maintained for 
>1 hour 
 
 Collection and reporting of a new denominator, Episodes of Mechanical Ventilation (EMV) will be introduced for 
VAE surveillance. 
EMV will be an optional denominator for VAE surveillance only. Ventilator Days and APRV days will continue to be 
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 NHSN HAI Surveillance Changes for 2015 (continued)  
PNEU/VAP Changes 
1. Purulent sputum will be determined by Gram’s stain / direct exam result, using the same definition defined in the 
VAE surveillance protocol.  
This laboratory confirmation is required to provide consistency since written clinical descriptions of purulence are 
highly variable. 
 Purulent sputum will be defined as secretions from the lungs, bronchi, or trachea that contain >25 neutrophils and 
<10 squamous epithelial cells per low power field (x100). 
 Because some clinical laboratories may use different result reporting formats for direct examinations of 
respiratory secretions, additional instructions for using the purulent respiratory secretions criterion will be 
provided. 
 
2. Pathogen exclusions for meeting PNEU/VAP definitions will mirror the VAE protocol pathogen exclusions. 
Pathogens that are not likely etiological agents of pneumonia and those typically acquired from the environment that 
are either not known to be acquired in healthcare settings, or have rarely been reported to be healthcare-associated 
will be excluded. 
 Yeast, coagulase negative Staphylococci, Enterococcus will be excluded unless isolated from lung tissue or pleural 
fluid when meeting PNU2 and PNU3 definitions. Candida spp. will continue to be included as a pathogen for 
meeting PNU3 (immunocompromised patients).  








3. Pathogen reporting and secondary bloodstream infection attribution for the PNU1 definition will not be permitted. 
If blood cultures are collected and pathogens are identified within the RIT then the PNU1 infection could be 
modified to PNU2 per protocol definitions.  
 
SSI Changes 
1. Infection Present at Time of Surgery 
Infection present at time of surgery (PATOS) will be a new field on the SSI Event form. PATOS denotes that an infection 
is present at the start of, or during, the index surgical procedure (in other words, it is present preoperatively).   
 PATOS doesn’t apply if there is a period of wellness between the time of a preoperative condition and surgery.  
 The infection must be noted/documented preoperatively or found intraoperatively in a pre-operative or 
intraoperative note.   
 Only select PATOS = YES if it applies to the depth of SSI that is being attributed to the procedure (e.g., if a patient 
had evidence of an intraabdominal infection at the time of surgery and then later returns with an organ space SSI 
the PATOS field would be selected as a YES. If the patient returned with a superficial or deep incisional SSI the 
PATOS field would be selected as a NO).  
 The patient does not have to meet the NHSN definition of an SSI at the time of the primary procedure but there 
must be surgeon notation that there is evidence of infection or abscess present at the time of surgery. 
o Example: Patient admitted with an acute abdomen, to OR for XLAP with finding of an abscess due to ruptured 
appendix, and an APPY is performed. Patient returns 2 weeks later and meets criteria for an organ space IAB 
SSI. The PATOS field would be selected as YES on the SSI event. 
o Example: Patient is admitted with a ruptured diverticulum and the surgeon notes that there are multiple 
abscesses in the intraabdominal space. Patient returns 3 weeks later and meets criteria for a superficial SSI. 
The PATOS field would be selected as NO, since there was no documentation of evidence of infection or 
abscess of the superficial area at the time of the procedure. 
 SSIs reported with PATOS = YES will be excluded from the SSI SIRs beginning with 2016 data and the new baseline. 
These excluded SSIs will be analyzed separately.       (SSI Changes continued on Page 9) 
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 NHSN HAI Surveillance Changes for 2015 (continued)  
SSI Changes (continued) 
2. HPRO and KPRO Revision Procedures 
For revision HPRO and KPRO procedures: If total or partial revision HRPO or KPRO is performed, also evaluate if any 
of the following ICD-9 diagnosis or procedure codes (below) were coded in the 90 days prior to and including the 
index HPRO or KPRO revision.  
 If any of the specified codes are recorded, mark yes on the denominator for procedure form to the data field 
“...was the revision associated with prior infection at index joint?” 
 It is not necessary to review the medical record for additional details concerning the prior infection; this 
variable is defined solely by the presence of one or more of the following ICD-9 codes associated with the index 
HPRO or KPRO procedure in the 90-day preoperative (including index revision) period. 
 84.56 - Insertion or replacement of (cement) spacer 
 84.57 - Removal of (cement) spacer 
 V88.21 - Acquired absence of hip joint, with or without the presence of an antibiotic - impregnated spacer 
 V88.22 - Acquired absence of knee joint, with or without the presence of an antibiotic - impregnated 
spacer 
Complications peculiar to certain specified procedures, infection and inflammatory reaction due to internal 
prosthetic device, implant and graft (extensions of 996, 996.6):  
 996.60 - Due to unspecified device, implant and graft 
 996.66 - Due to internal joint prosthesis 
 996.67 - Due to other internal orthopedic device, implant, and graft 
 996.69 - Due to other internal prosthetic device, implant, and graft 
 The prior infection at index joint field will be used as a new risk factor to be considered in the risk adjustment 
models for the new HPRO and KPRO 2015 baselines. 
 
3. Diabetes 
Along with the current NHSN definition of diabetes, assignment of the discharge ICD-9 codes in the 250 to 250.93 
range will be acceptable for use to answer YES to this diabetes field question. 
 
4. Change in “Scope” Field Reporting Instruction 
The reporting instruction for answering the SCOPE risk factor field will be updated. The instruction regarding the 
extension of a scope site will be removed. New instruction in the Table of Instructions will be: Check Y if the NHSN 
operative procedure was coded as a laparoscopic procedure performed using a laparoscope/robotic assist, 
otherwise check N.  
 
5. Definition of an Inpatient and Outpatient for Reporting NHSN Operative Procedures and SSI Events  
NHSN is reviewing the current definition and may be making revisions. We will notify users as soon as a final 
decision has been made. 
 
6. Transition to ICD-10-CM/PCS codes  
CDC continues to work on updated ICD-10-CM/PCS and CPT mappings to all NHSN operative procedure categories 
for SSI surveillance. These mappings are anticipated to be available by March 2015. ICD-10-CM/PCS codes will 
replace ICD-9-CM codes on October 1, 2015 but NHSN will not have the ability to receive these codes until the 
January 2016 release. The NHSN guidance for entry of surgical denominator data for the last quarter of 2015 data 
is to enter the NHSN Procedure Code (e.g. COLO or HYST) but do not enter any ICD-10-CM/PCS codes associated 
with the procedure. 
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 NHSN HAI Surveillance Changes for 2015 (continued)  
MDRO & CDI Changes 
1. Facility-wide Inpatient (FacWideIN) Monthly Denominator Reporting for Acute Care Hospitals (ACHs)  
For 2015 FacWideIN LabID Event reporting, acute care facilities are now required to exclude and indicate that 
inpatient locations that have a CCN that is different from the acute care facility (even if only different by a single 
letter in the 3rd position) have been removed from monthly FacWideIN denominator counts (patient days and 
admissions). Locations that will now be excluded may include but are not limited to inpatient rehabilitation 
facilities (IRFs) or inpatient psychiatric facilities (IPFs). If there are other locations within your facility that have 
separate CCNs for which you need further guidance, please contact the NHSN Helpdesk: NHSN@cdc.gov.  
 
Below is a screenshot of the 2015 MDRO & CDI summary data form showing the new fields that will be required in 


















As shown on the form, acute care facilities following FacWideIN surveillance will be required to show removal of 
the counts from locations with different CCNs. First the facility will enter a total count of patient days and 
admissions inclusive of all locations physically located in the hospital. Then the facility will enter the patient days 
and admissions of those denominator counts for the facility minus those locations with a separate CCN (e.g., IRF/
IPF). Further guidance for this updated reporting requirement will be provided in the coming months.  
 
2. MDRO and CDI LabID Event reporting for facility-wide inpatient (FacWideIN) will also require location-specific 
surveillance for that same organism in each emergency department(s) (pediatric and adult) and 24-hour 
observation location(s).  
Facilities participating in FacWideIN LabID Event reporting will be required to map and report outpatient LabID 
Events from emergency departments and 24-hour observation locations for the same organism and LabID Event 
type (i.e., All Specimens or Blood Specimens only). This means facilities will no longer assign the admitting inpatient 
location to LabID Events when specimens are collected in the emergency department or 24-hour observation 
location on the same calendar day as inpatient admission. This rule will facilitate accurate categorization of LabID 
Events, as well as allow each facility to capture community-onset cases.   
 
No Change: Specimens collected from any other affiliated outpatient location(s) should still be reported to an 




(MDRO & CDI Changes continued on Page 11) 
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 NHSN HAI Surveillance Changes for 2015 (continued)  
MDRO & CDI Changes (continued) 
3. Revisions to CRE definition and reporting requirements.   
 Additional CRE organism: CRE-Enterobacter, as defined in the MDRO and CDI protocol, will be added as an 
organism for CRE reporting.  
 CRE identification and reporting: For in-plan reporting of CRE, facilities will be required to conduct surveillance 
for and report all three CRE organisms (E.coli, Klebsiella pneumoniae/oxytoca, and Enterobacter), as defined in 
the MDRO and CDI protocol. Users will no longer be able to choose to monitor only one of the three CRE 
organisms for in-plan reporting.  
 CRE definition changes: The new CRE definition, as defined in the MDRO and CDI protocol, includes the 
following changes:  
o Addition of the drug ertapenem.  
o CRE will only include those pathogens that have tested ‘resistant’ to a carbapenem.  
o Surveillance for CRE-Klebsiella will be limited to Klebsiella oxytoca and Klebsiella pneumoniae.  
o New definition for CRE: Any Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, or Enterobacter 
testing resistant to imipenem, meropenem, doripenem, or ertapenem by standard susceptibility testing 
methods (i.e., minimum inhibitory concentrations of ≥4 mcg/mL for doripenem, imipenem and 
meropenem or ≥2 mcg/mL for ertapenem) OR by production of a carbapenemase (i.e., KPC, NDM, VIM, 
IMP, OXA-48) demonstrated using a recognized test (e.g., polymerase chain reaction, metallo-β-lactamase 
test, modified-Hodge test, Carba-NP). 
 
4. New “optional” questions added to Laboratory-identified MDRO or CDI Event form (CDC 57.128).  
The following “optional” questions will be added to improve tracking through the continuum of care for patients: 
 Last physical overnight location of patient immediately prior to arrival into facility (question available for LabID 
Events if the specimen is CO, i.e., collected from an outpatient setting or collected < 4 days after admission).  
 Has patient been discharged from another facility in past 4-weeks? If yes, from where (check all that apply). The 
following value set will populate: nursing home/skilled nursing facility; other inpatient healthcare setting (i.e., 
acute care hospital, IRF, LTAC, etc.). 
 
5. Clostridium difficile gastrointestinal system infection (GI-CDI) added as a specific infection type.  
A new infection surveillance definition for C. difficile will be added to the “CDC/NHSN Surveillance Definitions for 
Specific Types of Infections” chapter (Chapter 17). This new definition will be used by facilities reporting healthcare
-associated cases of C. difficile, but will not impact CDI LabID Event reporting.  
 
Clostridium difficile infection must meet at least 1 of the following criteria: 
i. Positive test for toxin-producing C. difficile on an unformed stool specimen (conforms to the shape of the 
container).* 
ii. Patient has evidence of pseudomembranous colitis on gross anatomic (includes endoscopic exams) or 
histopathologic exam. 
 
Additional information will be included in the reporting instructions for GI-CDI in Chapter 17. 
 
*Guidance for C. difficile testing can be found at: McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK. 
Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol. 2007; 
28(2):140-5 (ISSN: 0899-823X). 
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The NHSN Annual Hospital, LTAC, IRF, and LTCF surveys are being updated to include two new sections of questions for 
the 2014 survey (completed in early 2015): Infection Control Practices and Antibiotic Stewardship Practices. Questions 
about infection control practices have been added to gain a better understanding of current practices and identify 
areas to target prevention efforts among facilities that have reported multidrug-resistant organisms (MDROs). The 
information collected will inform future efforts to improve facility implementation of recommended prevention 
measures to control spread of MDROs. Questions about antibiotic stewardship have been added to the survey to 
obtain information regarding current facility efforts to improve antibiotic use and assess the quality of facility antibiotic 
stewardship programs. The information collected will inform efforts to improve facility implementation of best 
practices to improve antibiotic stewardship programs and antibiotic use in hospitals. 
 
Facilities can review the new questions when the updated NHSN forms and tables of instructions are posted on the 
NHSN website later this year. These revisions will be made to the surveys during the January 2015 update of NHSN. 
Therefore, facilities are asked to wait to complete their 2014 surveys until after the January 2015 update. Surveys 
completed prior to the January 2015 update will be deleted and users will be required to submit a new survey. 
Reminder emails will be sent to all facilities prior to January 1, 2015. 
NHSN Annual Facility Survey Expansion  
Mapping locations for CMS IPPS 2015 CLABSI and CAUTI Reporting  
We have started receiving questions from acute care hospitals (ACHs) with regard to the upcoming expansion in the 
reporting of CLABSI and CAUTI from ward locations in 2015 for CMS IPPS. That is, in addition to reporting CLABSI and 
CAUTI data from all adult, pediatric, and neonatal ICUs (CLABSI only), IPPS hospitals will also be required to report 
CLABSI and CAUTI data from adult and pediatric medical, surgical, and medical/surgical wards. 
 
Note that the requirement to report from ward locations will be limited to those locations that are mapped as/defined 







Any unit that meets the definition of – and is mapped as – a specific type that is not an ICU, NICU, or one of the six 
wards listed above (e.g., mapped as orthopedic ward, telemetry ward, step-down unit) will not be required for CMS 
IPPS reporting in 2015; any data reported from non-required units in NHSN will not be submitted to CMS. 
 
ACHs that are preparing for 2015 reporting should give careful consideration to the types of patients receiving care in a 
given unit in order to determine the most appropriate CDC location. Locations must be mapped and set-up in NHSN 
according to the guidance provided in the “Instructions for Mapping Patient Care Locations in NHSN” on page 2 of the 
CDC Locations and Descriptions chapter:  
http://www.cdc.gov/nhsn/PDFs/pscManual/15LocationsDescriptions_current.pdf.  
Patient Safety Component (PSC) Manual: Preparation for the 2015 Release  
Beginning with the January 2015 NHSN manual release, a comprehensive NHSN manual will be posted to the NHSN 
Website for easy access and printing. At that time, the 2014 protocols, forms, and Table of Instructions will be removed 
from the NHSN Website and will no longer be accessible to users. We encourage users to print/save a copy of the 2014 
PSC manual protocols, forms, and Tables of Instructions prior to December 2014. 
CDC Location Label CDC Location Code 
Medical Ward IN:ACUTE:WARD:M 
Medical/Surgical Ward IN:ACUTE:WARD:MS 
Surgical Ward IN:ACUTE:WARD:S 
Pediatric Medical Ward IN:ACUTE:WARD:M_PED 
Pediatric Medical/Surgical Ward IN:ACUTE:WARD:MS_PED 
Pediatric Surgical Ward IN:ACUTE:WARD:S_PED 
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Updates for Inpatient Psychiatric Facility (IPF) Locations within NHSN  
The January 2015 NHSN update will allow users with inpatient psychiatric ward locations that are CMS inpatient 
psychiatric facility (IPF) units within acute care and critical access facilities to appropriately designate the unit as a 
separately licensed CMS IPF. This functionality is similar to that used for CMS inpatient rehabilitation facility (IRF) units 
within acute care facilities. This applies only to those units whose CCN matches the acute care or critical access facility 
CCN and differs only by having an ‘M’ or ‘S’ in the 3rd position. It is essential to double check the CCN with the billing/
administrative departments at your facility prior to moving forward with location set-up. 
 
The updated functionality within NHSN will allow users to designate specific psychiatric locations within the facility as 
separately licensed CMS IPF units. In addition, users will be able to enter the IPF specific CCN, thus allowing the data to 
be appropriately excluded from the CMS Hospital IQR program requirements and included in the CMS IPFQR program 
requirements. Beginning with the 2015-2016 influenza season IPFs are required to report healthcare worker influenza 
vaccination summary data. The reporting period for this new requirement is October 1, 2015 – March 31, 2016. 
 
Facilities will be provided additional guidance on how to add the IPF specific CCN into NHSN later this year. 
New Reporting for Long Term Acute Care Facilities (LTACs):  
MRSA & CDI LabID Events  
Beginning on January 1, 2015, all Long Term Acute Care facilities (LTACs/LTCHs) will begin reporting Facility-wide 
Inpatient (FacWideIN) Methicillin-resistant Staphylococcus aureus (MRSA) Blood Specimen (Bacteremia) and 
Clostridium difficile Infection (CDI) Laboratory-Identified (LabID) Event data into NHSN. Because all LTACs are enrolled 
in NHSN as separate free-standing facilities, they will report these data using the FacWideIN location choice. 
Operational guidance documents detailing the reporting requirements will be posted within the next month at this 
webpage: http://www.cdc.gov/nhsn/cms/index.html.  
 
Facilities can prepare in advance for this reporting by reviewing the current NHSN MDRO & CDI Module Protocol and 
data collection forms and viewing the webinars providing example case studies on this webpage: http://www.cdc.gov/
nhsn/LTACH/mdro-cdi/index.html. However, we ask that facilities make sure to review and use the updated 2015 
NHSN Protocols once available. 
New Reporting for Inpatient Rehabilitation Facilities (IRFs):  
MRSA & CDI LabID Events 
Beginning on January 1, 2015, all Inpatient Rehabilitation Facilities (IRFs), both free-standing and units within affiliated 
acute care facilities, will begin reporting Facility-wide Inpatient (FacWideIN) Methicillin-resistant Staphylococcus aureus 
(MRSA) Blood Specimen (Bacteremia) and Clostridium difficile Infection (CDI) Laboratory-Identified (LabID) Event data 
into NHSN. Operational guidance documents detailing the reporting requirements will be posted in the coming months 
at this webpage: http://www.cdc.gov/nhsn/cms/index.html.  
 
Facilities can prepare in advance for this reporting by reviewing the current NHSN MDRO & CDI Module Protocol and 
data collection forms as well as viewing the webinars providing example case studies on this webpage: http://
www.cdc.gov/nhsn/inpatient-rehab/mdro-cdi/index.html. However, we ask that facilities make sure to review and use 




(IRF MRSA & CDI Reporting continued on Page 14) 
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New Reporting for Inpatient Rehabilitation Facilities (IRFs):  
MRSA & CDI LabID Events (continued) 
IRF units that are currently set up as locations within affiliated acute care facilities (i.e., have entered the IRF-specific 
CCN with a ‘T’ or ‘R’ in the 3rd position) will be able to report these data within the affiliated NHSN acute care facility. 
IRF units will report MRSA and CDI LabID event data by IRF location (whereas acute care facilities and free-standing 
IRFs will report using the FacWideIN location choice). Below is a screenshot demonstrating how to set up the monthly 








NHSN, the 24-hour 
observation and 
rehab unit locations 
are not able to select 
‘MRSA blood 
specimens only’ on 
the monthly reporting 
plan. This will be 
changed in the 
January 2015 update 
of NHSN to allow CMS 
IRF units to select this 
option on the 
monthly reporting 
plan. Facilities are 
welcome to wait to 
complete 2015 
monthly reporting 
plans after the 
January 2015 NHSN 
update or edit the 
existing 2015 monthly 
reporting plans to 
select the ‘MRSA 
blood specimens only’ 
for the CMS IRF unit 
when that option is 
available after the 
January 2015 NHSN 
update.  
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Patient Safety Component Analysis Updates for January 2015  
The items listed below provide a brief summary regarding changes and additions to the Patient Safety Analysis Output 
Options that will be implemented in January 2015. More details regarding these changes will be provided in early 2015. 
 
Updates  
 Addition of Ward locations in the CLABSI and CAUTI CMS IPPS SIRs 
Locations defined as an adult or pediatric medical, surgical, or medical/surgical ward will be included in the CMS 
IPPS CLABSI and CAUTI SIRs beginning with Q1, 2015 data. In addition, a separate table will still be produced in the 
CMS IPPS SIRs output that will provide an SIR inclusive of only adult, pediatric, and neonatal ICUs. 
 
 Update to Device-associated Pooled Means 
CLABSI, CAUTI, and VAP rate tables will be updated such that the NHSN pooled means and percentiles will 
represent the Data Summary for 2013.  
 
Please note the following: 
o The new pooled means for Long Term Acute Care Facilities (LTACs/LTACHs) and Inpatient Rehabilitation 
Facilities (IRFs) will be used as the baseline data for new SIRs for these facility types. Additional details are 
provided below. 
o Pooled means for VAP will only be provided for select pediatric ICU and NICU locations. 
 
As a reminder, CLABSI SIRs for acute care hospitals produced in 2015 will continue to use a baseline of 2006-08 
national data, and CAUTI SIRs for acute care hospitals produced in 2015 will continue to use a baseline of 2009 
national data. The 2015 data will then serve as the baseline for SIRs produced in 2016 and forward. 
 
 REMINDER: Upcoming Retirement of “All Device-Associated Events” Set of Output Options 
As mentioned in the June 2014 Newsletter, in January, NHSN will retire the five output options that appear in the 
“All Device-Associated Events” Output Options folder. The following output options will be removed: 
o Line Listing - All Device-Associated Events 
o Frequency Table - All Device-Associated Events 
o Bar Chart - All Device-Associated Events 
o Pie Chart - All Device-Associated Events 
o Rate Table - All Device-Associated Data 
 
We strongly encourage the use of event-specific output options for those who have grown accustomed to using 
the “All Device-Associated Events” set of output options. Note that Custom Output Sets can be created such that a 
user can include multiple output options in a single “run” of a report. Instructions for creating a Custom Output Set 
are available at: http://www.cdc.gov/nhsn/PS-Analysis-resources/PDF/OutputSet.pdf.   
 
 Addition of MRSA bacteremia and CDI LabID Indicator Variables 
In an effort to aide facilities and groups with determining which MRSA blood and CDI events are included in 
FACWIDEIN rates and SIRs, we are adding four indicator variables to those LabID event line lists. These variables 
will be given a value of “1” if the event is included in the associated measure. For example, if the new variable 
“FWMRSA_bldIncCount” is equal to 1, then that event will be included in the number of healthcare facility onset 
(HO) MRSA bacteremia events for the “SIR - MRSA Blood FacwideIN LabID Data” output option. 
 
 
(PS Analysis Updates continued on Page 16) 
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Patient Safety Component Analysis Updates for January 2015 (continued) 
Updates  (continued) 
 Changes to CLIP Bundle Adherence for patients <120 days of age 
To address updates to chlorhexidine gluconate product labeling which states “…use with care in premature infants 
or infants under 2 months of age. These products may cause irritation or chemical burns”, beginning in 2015, NHSN 
will allow for CLIP bundle adherence when there are contraindications in patients less than 120 days of age at the 
time of insertion. NHSN is using 120 days rather than 60 days as the cut off in order to account for clinician 
concerns about extremely premature infants whose skin continues to be very sensitive. 
 
The following will be identified as appropriate skin prep for NHSN CLIP documentation:   
o Chlorhexidine gluconate (CHG) for patients ≥120 days old 
o CHG for patients <120 days old when either there is no contraindication to CHG or contraindication is unknown 
o Povidone iodine, alcohol, CHG, or other specified for children <120 days old when there is a contraindication to 
CHG 
 
NOTE: If the baby’s age is the reason for non-use of CHG, the data field for contraindication to chlorhexidine must 
be marked “Yes” for the skin prep to be identified as adherent in the CLIP bundle adherence in analysis.   
 
CLIP analysis datasets and output options within NHSN will be updated to allow for the new skin prep rules when 
determining bundle adherence. Additional details regarding the changes to the CLIP output options will be 
provided in early-2015.  
 
This is a temporary modification to address a product labeling change. In order to accommodate the related work 
required of software vendors, a final modification is not possible until January 2016. More details will be provided 
before that change is made.  
 
New Output Options 
 Analysis Options for HAI Antimicrobial Resistance 
New analysis reports will allow users to view and analyze antimicrobial resistance from Device-Associated (DA) and 
Procedure-Associated (PA) HAIs. Pre-defined resistant phenotypes will be included in the output (e.g., MRSA, CRE, 
etc.), however users can modify the output as needed to define their own pathogens and drug susceptibilities. A 
line list and frequency table will be available to view event-level data with resistant or non-susceptible pathogens 
reported. In addition, a rate table will display the percent of all pathogens that tested resistant or non-susceptible 
to the applicable drugs.  
 











(PS Analysis Updates continued on Page 17) 
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Patient Safety Component Analysis Updates for January 2015 (continued) 
New Output Options (continued) 
 Output Options for the Targeted Assessment for Prevention (TAP) Strategy 
The TAP strategy allows for the ranking of facilities (or locations) in order to identify and target those areas with 
the greatest need for improvement. New output options, referred to as “TAP Reports”, will be available for 
facilities and groups and will be generated for CLABSI, CAUTI, and CDI LabID data. 
 
 Device-associated SIRs for LTACs and IRFs  
New output options will be added so that LTACs will be able to run CLABSI and CAUTI SIRs, and IRFs will be able to 
run CAUTI SIRs; each of these SIRs will use the upcoming 2013 device-associated pooled means as the baseline. 
These SIRs will be available as new standard reports in the “Device-Associated Module” output options folder, as 
well as in the “CMS Reports” folder. Acute care hospitals with a CMS IRF unit will need to run the IRF-specific CAUTI 
SIRs as these data will not be included in the existing acute care hospital CAUTI SIR output options. 
 
 CDI and MRSA Blood LabID CMS reports for LTACs and IRFs 
New analysis reports will be available for LTACs and IRFs reporting C. difficile and MRSA Bacteremia LabID Events as 
part of CMS Quality Reporting Programs. These reports will consist of a single facility-wide incidence rate, and will 
be available for 2015 Q1 data and forward. NOTE: For CMS IRF locations within an acute care hospital, a location-
specific incidence rate table will be displayed in this report.   
 
Incidence rates will include incident, hospital-onset LabID events identified in patients with no LabID events (in any 
location) in the previous 14 days, divided by the total applicable number of patient-days. The new CMS reports will 
be located under the appropriate folder within the “CMS Reports” analysis folder.  
 
 Output Options for CRE-Enterobacter and all CRE combined 
Due to the redefined, all-inclusive reporting for CRE, output options will be added so that users can generate 
reports for CRE-Enterobacter, as well as for all three CRE combined, in addition to the existing CRE-E.Coli and CRE-
Klebsiella output options. These options will be available for LabID and Infection Surveillance and will include the 
standard reports (i.e., line lists, frequency tables, rate tables, bar charts, and pie charts).  
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NHSN Facility Enrollment & Set-up Checklist for ASCs 
CMS licensed ASCs participating in the CMS ASC Quality Reporting (ASCQR) Program are required to report data on 
healthcare personnel influenza vaccination counts into NHSN for the 2014-2015 influenza season. ASCs should begin 
the NHSN facility enrollment process as soon as possible in order to ensure ample time to complete the enrollment 
process and report the HCP influenza vaccination summary data. NHSN has developed ASC-specific guidance for enrol-
ling into NHSN and setting up the facility to report these data. The checklist can be found here: http://www.cdc.gov/
nhsn/ambulatory-surgery/enroll.html.  
Healthcare Personnel Safety Component 
Reminders for 2014-2015 Influenza Vaccination Summary Data Reporting  
Acute Care Facilities: Beginning with the 2014-2015 influenza season, acute care facilities participating in the CMS 
IPPS Hospital Inpatient Quality Reporting Program and Outpatient Quality Reporting Program must submit summary 
data on influenza vaccination of healthcare personnel (HCP) physically working in all inpatient or outpatient units that 
are physically attached to the inpatient acute care facility site and share the same CMS certification number (CCN), 
regardless of the size or type of unit. Acute care facility training materials are located at: http://www.cdc.gov/nhsn/
acute-care-hospital/hcp-vaccination/index.html.  
 
Please note: CDC is expanding guidance that was previously provided to acute care hospitals reporting healthcare 
personnel (HCP) influenza vaccination summary data to NHSN in fulfillment of CMS’s Hospital Inpatient Quality 
Reporting (IQR) and Hospital Outpatient Quality Reporting (OQR) Program Requirements for the 2014-2015 influenza 
season.  
 
Acute care facilities that participate in both the CMS IQR and OQR programs must report a single combined healthcare 
personnel influenza vaccination summary for HCP physically working for at least one day between October 1 and 
March 31 within the acute care inpatient facility and all hospital outpatient units/departments (HOPDs) that share the 
exact same CCN and service the particular NHSN facility regardless of the physical location of the HOPD. HCP working 
in these inpatient and outpatient departments and meeting NHSN protocol definitions should be included in the NHSN 
acute care hospital counts as outlined by the below guidance and examples. 
 
Include HCP working in HOPDs with affiliated acute care facility inpatient counts only if: 
 
a. HOPD shares the exact same CCN as the acute care facility (100% identical; must not differ by even one letter/
number).  
And   
b. HOPD is affiliated with the specific acute care facility (such as sharing medical privileges or patients), regardless 
of distance from the acute care facility. 
 
For example:  
 A hospital-owned outpatient wound care clinic is co-located on the same medical campus as an acute care facility 
and functions as a unit of the acute care facility. The wound care clinic shares the exact same CCN as the acute care 
facility; therefore, the wound care clinic would be included in the acute care facility counts since it meets both of 
the required inclusion criteria.     
 
 A physician clinic is co-located on the same medical campus as an acute care facility, but it does not share the exact 
same CCN as the acute care facility. The clinic would not be included in the acute care facility counts since it does 
not meet both of the required inclusion criteria. 
 
(Flu Vaccination Summary Reporting continued on Page 19)  
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Reminders for 2014-2015 Influenza Vaccination Summary Data Reporting 
(continued) 
Acute Care Facilities HOPD examples continued... 
 An outpatient lab and imaging facility is located one mile away from an acute care facility. The department shares 
the same CCN as the acute care facility and refers patients to the acute care facility for follow-up. The outpatient 
lab and imaging facility would be included in the acute care facility’s counts since it meets both of the required 
inclusion criteria.     
 
 A free-standing emergency department (ED) is located down the street from the acute care facility. The ED shares 
the same CCN and is affiliated with the acute care facility as it sends patients to the facility for further treatment. 
The free-standing ED would be included in the acute care facility’s counts since it meets both of the required 
inclusion criteria.   
 
 A free standing emergency department (ED) is located three miles away from two separate medical campuses, 
each of which has an acute care facility. All three share the same CCN and the two acute care hospitals are enrolled 
as separate facilities within NHSN (i.e., two separate NHSN Facility OrgID#s). The ED has medical privileges and 
services patients for only one of the acute care facilities. The free-standing ED would be included in that acute care 
facilities’ separate HCP influenza vaccination summary counts since it meets both of the required inclusion criteria. 
However, it would not be included in the other acute care facility’s separate HCP influenza vaccination summary 
counts since it does not meet the 2nd required inclusion criteria (HOPD is affiliated with the specific acute care 
facility, such as sharing medical privileges or patients). 
 
Training materials and FAQs will be updated with this expanded guidance within the next few weeks. If you require 
further guidance on this issue, please e-mail the NHSN HelpDesk at NHSN@cdc.gov and include “HPS Flu Summary” in 
the subject line along with your facility type. 
 
Ambulatory Surgery Centers (ASCs): CMS licensed ASCs participating in CMS’s ASC Quality Reporting Program are 
required to submit HCP influenza vaccination summary data for the 2014-2015 influenza season. ASC training materials 
are located at: http://www.cdc.gov/nhsn/ambulatory-surgery/hcp-vaccination/index.html. 
 
Inpatient Rehabilitation Facilities (IRFs): IRFs participating in CMS’s IRF Quality Reporting Program are required to 
submit HCP influenza vaccination summary data for the 2014-2015 influenza season. IRF training materials are located 
at: http://www.cdc.gov/nhsn/inpatient-rehab/hcp-vacc/index.html.   
 
Long Term Acute Care (LTAC) Facilities: LTACs participating in CMS’s LTCH Quality Reporting Program are required 
to submit HCP influenza vaccination summary data for the 2014-2015 influenza season. LTAC training materials are 
located at: http://www.cdc.gov/nhsn/LTACH/hcp-flu-vac/index.html.  
 
 
Facility-specific operational guidance documents regarding HCP influenza vaccination summary data reporting are 
located at: http://www.cdc.gov/nhsn/cms/index.html. Live training webinars were offered in August for the 2014-2015 
influenza season. The webinar re-casts and PowerPoint slides are available at: http://www2.cdc.gov/vaccines/ed/
nhsn/.   
 
For questions related to HCP influenza vaccination summary data reporting, please e-mail NHSN@cdc.gov and specify 
‘HPS Flu Summary’ in the subject line, along with your facility type.  
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With the successful launch of the Dialysis Component in August 2014, the Dialysis NHSN Team has shifted focus to 
preparations needed for 2015. Existing protocols are being reviewed for clarity and information is being added to 
address common questions. In addition, new protocols and instructions for new surveillance options are under way. 
New resources should clarify reporting requirements, provide options for monitoring best practices for infection 
prevention, and maximize the use of NHSN. 
 
What new reporting features should outpatient dialysis users expect in 2015?  
1. New Prevention Process Measures (PPM)—Five new prevention process measures are being added to the Dialysis 
Component. In addition to the existing Hand Hygiene option, a summary of audit results can be reported for the 
following items: 
o Hemodialysis Catheter Connection/Disconnection  
o Hemodialysis Catheter Exit Site Care  
o Arteriovenous Fistula and Graft Cannulation/Decannulation  
o Dialysis Station Routine Disinfection 
o Injection Safety  
 
Monthly Reporting Plan: Participation in PPMs, including Hand Hygiene, is voluntary. Reporting to PPMs is not a 
part of the CMS ESRD QIP requirements. Dialysis users will have the option to select one to six PPMs on the 
Monthly Reporting Plan. “In-plan” reporting requires a minimum number of monthly observations (audits), which 

















Analysis & Reports: New line listings will be available for both facility and group users to run in Analysis to 
determine their percent adherence for each PPM type.  
 
Define/Confer Rights: Facilities will see an updated Confer Rights template where they can choose to share 
information on their optional PPM selections with their Network or other group.  
 
New Supplemental Materials: A table of instructions and an updated PPM protocol will be available in early 2015, 
so stay tuned!           (Dialysis Updates continued on Page 21) 
2015 Updates to the NHSN Dialysis Component  
Dialysis Component 
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2. The new Influenza Vaccination for Dialysis Patients Module is now available and instructional information is on 
the way!—The Influenza Vaccination for Dialysis Patients Module allows facilities to monitor influenza vaccinations 
of all patients receiving in-center hemodialysis, home hemodialysis, and peritoneal dialysis who are 6 months or 
older.  
 
Web Resources: The new webpage, “Surveillance for Dialysis Patient Influenza Vaccination,” contains data 
collection forms: http://www.cdc.gov/nhsn/dialysis/patient-flu-vacc/index.html. Supporting materials such as the 
“Influenza Vaccination for Dialysis Patients Protocol” and a table of instructions will be posted shortly.  
 
Analysis & Reports: A new report to calculate dialysis patient influenza vaccination adherence will be added to 
Analysis. 
 
3. New Data Quality Reports in Analysis—Upholding data quality by reporting complete and accurate data is a 
fundamental part of NHSN. Therefore, new line listings will be available under the new “Data Quality” folder in 
Analysis to help users identify potential events for review. Both facility and group users will be able to use these 
reports to check for:  
 Potential 21-day rule violations 
 Signs of underreporting  
 
4. Adjustments to the Dialysis Event form—In response to feedback from our NHSN users and partners, a new 
question will be added to the Dialysis Event form for positive blood culture events: “Where was this positive blood 
culture collected?” Users can indicate blood was collected in the “Dialysis Clinic,” in the “Hospital (on the day of or 
day following hospital admission) or Emergency Department,” or in an “Other location.” This will help facilities 
determine how well they are capturing all positive blood culture reports in accordance with the Dialysis Event 
Protocol. In Analysis, the new variable will be added to existing reports, and will be used to quantify the number of 







“Loss of Vascular Access” will now be a required field. The instruction for this field, found in the Tables of Instruc-
tion for the Dialysis Event form, is to select “Yes” if the dialysis event(s) or problem(s) contributed to a loss of the 
patient’s vascular access (i.e., the vascular access required removal or became unusable). Examples of vascular 
access loss: infection necessitating the removal of a central venous catheter or graft, or rendering a fistula or graft 















Questions? Email the NHSN Helpdesk at NHSN@cdc.gov and include “Dialysis Event” in the subject line. 
2015 Updates to the NHSN Dialysis Component (continued) 
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Biovigilance Component Updates  
Facility Outreach to Improve Data Reporting 
In order to improve data reporting by facilities, we will be emailing facilities with missing adverse reaction, 
denominator, and annual survey records as well as facilities without a Biovigilance Component user with Administrator 
rights. These emails will be sent to your facility’s Biovigilance Component Primary Contact. Please confirm that your 
Biovigilance Component Primary Contact is up to date.   
 
Analysis Output Options – Rate Tables  
Facilities can generate adverse reaction and incident rate tables within the Hemovigilance Module. The Adverse 
Reaction rate table provides individual rates for each adverse reaction type as well as an overall rate for all adverse 
reactions. The incident rate tables provide rates for incidents related to samples and incidents related to products.  
 
In order for a facility’s data to be included in facility-specific rate calculations, numerator (Adverse Reaction and 
detailed Incident forms) and denominator (Monthly Reporting Denominators form) data for each month must be 
reported.  
 
Hemovigilance Module Surveillance Protocol Update 
Section 1 of the surveillance protocol has been updated to include a suggested citation for the Hemovigilance Module 
Surveillance Protocol. If you have questions regarding citing the Hemovigilance Module Surveillance Protocol, email us 
at NHSN@cdc.gov. Include ‘Biovigilance’ in the subject line of the email for appropriate routing.  
Biovigilance Component 
General NHSN Information 
Important SAMS Update 
As many of you know from the recent blast email that was sent, CDC has been migrating away from the issuance of 
digital certificates to access programs like NHSN and will now use The Secure Access Management System (SAMS) in its 
place. The migration has been going well and CDC has decided to no longer issue any NEW digital certificates. This news 
has caused an influx in the number of user requests for SAMS invites, increasing the turnaround time for proofing. The 
proofing process normally takes 2 weeks, but could take up to 30 days. When you do receive your SAMS invitation, we 
urge you to act promptly as the process for SAMS is considerably longer than the process for receiving a digital 
certificate.   
Please be especially aware of expiring digital certificates that fall close to CMS and state reporting deadlines, as the 
NHSN Team will not be able to assist in moving the process along any more quickly than it must occur, and there is no 
longer the option to rely on a digital certificate renewal as a quick backup. It is also important to note that once a user 
is able to access NHSN Reporting via SAMS, if they have an active digital certificate, CDC will remove the activities from 
these digital certificates, which will prevent them from accessing the system through this old pathway.    
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NHSN Enrollment Update 
NHSN Enrollment Update (as of October 1, 2014): 
5,838 
Hospitals (this includes 571 Long-term Acute Care Hospitals and 302 Free-
standing Inpatient Rehabilitation Facilities) 
6,552 Outpatient Hemodialysis Facilities 
800 Ambulatory Surgery Centers (ASCs) 
259 Long-term Care Facilities 
13,449 Total Healthcare Facilities Enrolled 
The National Healthcare Safety Network (NHSN) is a voluntary, secure, Internet-based surveillance system that integrates patient and 
healthcare personnel safety surveillance systems managed by the Division of Healthcare Quality Promotion (DHQP) at CDC. 
During 2008, enrollment in NHSN was opened to all types of healthcare facilities in the United States, including acute care hospitals, long-
term acute care hospitals, psychiatric hospitals, rehabilitation hospitals, outpatient dialysis centers, ambulatory surgery centers, and long 
term care facilities. 
The Centers for Disease Control and Prevention (CDC) 
MS-A24, 1600 Clifton Road, Atlanta, GA 30333 
E-mail: NHSN@cdc.gov; CDC’s NHSN Website: www.cdc.gov/nhsn 
CDA Corner 
The following CDA versions are transitioning to be based on the R2_D1.1 Implementation Guide. The new CDA versions 








Denominator CDA Changes 
8.3 Early 2015 SSI 
R9 CDA required if procedure date =2014 
R2N-D1.1 CDA required if procedure date ≥2015 
8.3 Early 2015 Procedure 
R9 CDA required if procedure date =2014 
R2N-D1.1 CDA required if procedure date ≥2015 
8.3 Early 2015 Dialysis 
r9 CDA required if event date =2014 
R2N-D1.1 CDA required if event date ≥2015 
8.3 Early 2015 UTI 
R5 CDA required if event date <2015 
r2N-D1.1 CDA required if event date ≥2015 
